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Abstract
Background: During granulopoiesis in the bone marrow, the nucleus differentiates from ovoid to
lobulated shape. Addition of retinoic acid (RA) to leukemic HL-60 cells induces development of
lobulated nuclei, furnishing a convenient model system for nuclear differentiation during
granulopoiesis. Previous studies from our laboratory have implicated nuclear envelope composition
as playing important roles in nuclear shape changes. Specifically noted were: 1) a paucity of lamins
A/C and B1 in the undifferentiated and RA treated cell forms; 2) an elevation of lamin B receptor
(LBR) during induced granulopoiesis.
Results: The present study demonstrates that perturbation of cytoskeletal elements influences
nuclear differentiation of HL-60 cells. Because of cytotoxicity from prolonged exposure to
cytoskeleton-modifying drugs, most studies were performed with a Bcl-2 overexpressing HL-60
subline. We have found that: 1) nocodazole prevents RA induction of lobulation; 2) taxol induces
lobulation and micronuclear formation, even in the absence of RA; 3) cytochalasin D does not
inhibit RA induced nuclear lobulation, and prolonged exposure induces nuclear shape changes in
the absence of RA.
Conclusions: The present results, in the context of earlier data and models, suggest a mechanism
for granulocytic nuclear lobulation. Our current hypothesis is that the nuclear shape change
involves factors that increase the flexibility of the nuclear envelope (reduced lamin content),
augment connections to the underlying heterochromatin (increased levels of LBR) and promote
distortions imposed by the cytoskeleton (microtubule motors creating tension in the nuclear
envelope).
Background
Granulopoiesis, the differentiation of peripheral blood
granulocytes, involves dramatic nuclear and cytoplasmic
structural changes [1]. Committed bone marrow progeni-
tor cells possess ovoid-shaped nuclei with prominent
nucleoli and a paucity of heterochromatin. The mature
terminally differentiated human neutrophil (polymor-
phonuclear granulocyte) exhibits a distinctly lobulated
(segmented) nucleus with shrunken nucleoli and exten-
sive peripheral heterochromatin. The mature neutrophil
is released into the bloodstream, where it circulates as a
round unpolarized cell. Responding to chemotactic
agents produced by infection and tissue damage, the cir-
culating neutrophil changes cell shape, converting to a
rapidly migrating polarized cell. Mature granulocytes have
a limited lifespan, succumbing to apoptosis within a few
days following release into the bloodstream.
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Several established tissue culture cell lines have been
investigated as model systems for understanding the
events and mechanisms of granulopoiesis [2]. Previous
studies from our laboratory have employed the HL-60 cell
system to examine nuclear lobulation and cytoskeletal
polarization [3-5]. HL-60 cells exhibit granulocytic differ-
entiation in response to added retinoic acid (RA) [6],
eventually undergoing apoptotic death [7]. Our studies
on RA induced granulocytic differentiation of HL-60 cells
implicated two major factors in the nuclear lobulation
process: 1) very low cellular levels of lamins A/C and B1;
2) a significant increase in cellular levels of lamin B recep-
tor (LBR). Ultrastructural studies suggested that during
nuclear differentiation, nuclear envelope surface area was
increased [3]. In addition to nuclear lobulation, these
studies demonstrated the formation of extensive nuclear
envelope outgrowths, denoted "nuclear envelope-limited
chromatin sheets" or ELCS. The suspected role of LBR was
confirmed in subsequent studies [8,9], which demon-
strated that a genetic deficiency of LBR correlates with
hypolobulated granulocyte nuclei in the human Pelger-
Huet anomaly [8] and the murine Ichthyosis mutation
[9]. LBR is an integral membrane protein of the nuclear
envelope inner membrane, with putative interactions to
lamin B, chromatin and HP1α [10]. The mechanistic rela-
tionships between changes in nuclear envelope composi-
tion and granulocytic nuclear lobulation are currently
unknown.
The position of the interphase nucleus within the cell
appears to be regulated by microtubules and associated
dynein [11] and actin and associated spectrin-like pro-
teins [12-15]. However, only fragmentary data exists
examining the relationship, if any, between cytoskeletal
elements and nuclear shape. Absence of intermediate fila-
ments (vimentin) has been correlated with nuclear enve-
lope folds or invaginations [16]. Employing HL-60 cells,
evidence has been published that neither microtubules
(MTs) nor the actin microfilament system are essential for
the establishment of nuclear lobulation [17]. Our labora-
tory chose to investigate these conclusions concerning
HL-60 cells in greater detail. Employing the same cell sub-
line (HL-60/S4), we demonstrated that brief (i.e., 2 and 4
hour) treatments of undifferentiated or granulocytic (RA
treated) cells with various cytoskeletal modifying chemi-
cals had no obvious effects upon nuclear shape, although
cell shape was strongly affected [4]. However, prolonged
(i.e., 2 day) exposure of undifferentiated HL-60/S4 cells to
nocodazole (NC, disrupts MTs) or taxol (TX, stabilizes
MTs), but not cytochalasin D (CD, disrupts actin microfil-
aments), resulted in rapid apoptotic death. For this rea-
son, the present study emphasizes the prolonged exposure
of cytoskeleton-modifying chemicals on Bcl-2 overex-
pressing HL-60 cells [18,19]. These cells are more refrac-
tory to undergoing apoptosis, but can still be induced
with RA to exhibit granulocytic differentiation. Employ-
ing HL-60-bcl-2 cells [18], we demonstrate that the integ-
rity of the MTs system, but not the actin microfilament
system, is essential for the nuclear lobulation process dur-
ing in vitro granulopoiesis. Prolonged exposure of HL-60-
bcl-2 cells to CD or TX does lead to perturbations of
nuclear shape, independently of RA induced nuclear
differentiation.
Results
HL-60/S4 cells undergo retinoic acid induced nuclear 
lobulation in the presence of cytochalasin D, but do not 
survive nocodazole or taxol treatment
HL-60/S4 cells were cultivated for up to four days in
medium with (or without) 1 µM RA and with (or without)
1 µM CD. Daily samples of these four cultivation condi-
tions were cytospun on microscope slides and Wright-
Giemsa stained for examination. The image data from day
3 are presented (Figure 1a,1b,1c,1d). Control cells (Figure
1a; no RA or CD) possessed single ovoid nuclei (>99% of
cells) throughout the entire period; CD treatment alone
(Figure 1b) exhibited primarily multinucleated cells. RA
treated controls (Figure 1c; no CD) revealed clear nuclear
indentation and lobulation by day 3 [3]; RA plus CD
treated cells revealed indented and lobulated multiple
nuclei (Figure 1d). HL-60/S4 cells exposed to 1 µM CD,
with or without RA, became mostly multinucleated by day
3 (approximately 4% mono-, 56% bi-, 20% tri-, and 18%
tetranucleated). Evidence of apoptosis became apparent
by day 4. In addition, immunostaining of RA plus CD
treated cells (day 4) with anti-lamin B (data not shown)
clearly indicated stained "patches" between nuclear lobes,
interpreted as ELCS [3]. These results are in complete
agreement with a previous publication [17], and moni-
tored HL-60/S4 nuclear differentiation for a longer
period.
The previous publication [17] also examined the role of
MTs on nuclear lobulation in HL-60/S4 cells. They
exposed RA treated cells to 0.1 µM (0.03 µg/ml) NC for up
to two days, concluding that the integrity of MTs was not
important to the formation granulocytic nuclear lobes.
We repeated this experiment, including a separate com-
parison of HL-60/S4 cells exposed to 0.1 µM TX. The
results clearly indicated ~100% apoptotic cell death by
day 2 with either NC or TX, preventing any firm conclu-
sion of whether MT integrity is important for nuclear lob-
ulation. We concluded that exploration of this issue
would be better accomplished using HL-60-bcl-2 cells,
which are more refractory to undergoing rapid apoptosis.
HL-60-bcl-2 cells exhibit nuclear lobulation in response to 
retinoic acid
Bcl-2 overexpressing HL-60 cells remain viable for longer
periods than the parent cell line, following exposure to RABMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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[18,19]. A significant fraction of RA treated cells survive
for up to two weeks; some even for three weeks, exhibiting
granulocytic characteristics including: nuclear lobulation,
surface antigen expression and nitroblue tetrazolium
reduction [18,19]. Figure 2 presents a morphological
analysis of Wright-Giemsa stained HL-60-bcl-2 cells for up
to three weeks following addition of 1 µM RA. For the sake
Wright-Giemsa stained HL-60 cells following exposure to RA and CD Figure 1
Wright-Giemsa stained HL-60 cells following exposure to RA and CD. HL-60/S4 cells (Panels a-d): a, undifferentiated; 
b, 1 µM CD; c, 1 µM RA; d, 1 µM RA plus 1 µM CD. Three days of drug exposure. HL-60-bcl-2 cells (Panels e-h): e, undifferen-
tiated; f, 1 µM CD; g and h, 1 µM RA plus 1 µM CD. Seven days of drug exposure. Scale bar: 10 µm.
Nuclear differentiation during RA induced granulopoiesis of  HL-60-bcl-2 cells monitored by Wright-Giemsa staining Figure 2
Nuclear differentiation during RA induced granulo-
poiesis of HL-60-bcl-2 cells monitored by Wright-
Giemsa staining. Examples of the four nuclear morpholog-
ical states: a, ovoid; b, indented; c, lobulated; d, lobulated 
(left) and multilobed (right); e and f, multilobed. Scale bar: 10 
µm.
Time course of nuclear differentiation in RA treated HL-60- bcl-2 cells over a three-week period Figure 3
Time course of nuclear differentiation in RA treated 
HL-60-bcl-2 cells over a three-week period. The per-
centage of cells in each of the four nuclear categories from 
day 0 to day 21 (following addition of RA): ovoid; indented; 
lobulated; multilobed.
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of analysis, we distinguished four nuclear morphology
categories: ovoid (Figure 2a), indented (Figure 2b), lobu-
lated (Figures 2c and 2d left) and multilobed (Figures 2d
right, 2e and 2f). A multilobed granulocytic nucleus is one
that displays five or more lobes, a diagnostic hematologi-
cal criterion observed in blood smears from humans with
megaloblastic anemia [20]. Figure 3 is a graphical repre-
sentation of nuclear morphological changes during RA
induced granulocytic differentiation. At one week follow-
ing addition of RA, ~80% of the cells reveal nuclear differ-
entiation, with ~95% viability (trypan blue exclusion).
From 12 to 21 days post-addition of RA, small changes in
the distribution of nuclear morphologies are apparent.
Also during this period, cellular debris from dying cells
becomes increasingly evident. These observations are in
agreement with detailed viability measurements [18],
which indicate a significant loss of viability after ~14 days
post addition of RA.
An immunoblotting analysis from total cell extracts of RA
differentiating HL-60-bcl-2 cells is presented in Figure 4,
focusing upon nuclear envelope components. For a
detailed comparison with total cell extracts from differen-
tiating HL-60/S4 cells, see [5]. Based upon densitometric
analyses from three separate immunoblotting experi-
ments, LBR showed an increased amount for days 7 to 14
(~2 to 3-fold, compared to the level at day 0). This
increase was seen with both the expected ~70 kD protein
band and a ~53 kD band, which may represent a proteo-
lytic product [4]. By contrast, other nuclear proteins
(lamin B2, LAP2 α, LAP2 β and emerin) exhibited little-
or-no increase in levels, but revealed decreases (especially
after day 12). LAP2 β and emerin consistently revealed
double bands, which might represent protein modifica-
tion (e.g., phosphorylation). The low levels of lamins A/C
and B1 revealed a relative constancy throughout the
period of RA-induced granulocytic differentiation, con-
sistent with earlier observations on HL-60/S4 cells [5].
The loss of proteins on (or after) day 12 may reflect a com-
bination of programmed gene expression and pro-
grammed protein degradation. Therefore, experiments on
the effects of various cytoskeleton-modifying drugs upon
HL-60-bcl-2 cells were confined to a 10-day period follow-
ing the addition of RA.
Confocal immunofluorescence studies of HL-60-bcl-2 
reveal the existence of micronuclei
Immunofluorescent staining was performed on undiffer-
entiated and RA treated HL-60-bcl-2 cells to better docu-
ment nuclear shape and antigen localization. In the
course of the experiments on undifferentiated cells, we
discovered that ~10% of the cells exhibited one or more
micronuclei, in close proximity to the main nucleus. Fur-
thermore, co-localization experiments revealed that the
vast majority of micronuclei contained lamin B, but
reduced levels of LBR, in comparison to the adjacent main
nucleus. Figure 5 presents a gallery of anti-LBR and anti-
lamin B stained cells with a single main nucleus and adja-
cent micronuclei. As revealed by TO-PRO-3 staining, the
micronuclei also contained DNA. During granulocytic
differentiation the round micronuclei continue to be
visualized, even as the main nuclei are undergoing inden-
tation and lobulation (Figure 6). Again the majority of
micronuclei maintain a relative deficiency of LBR, com-
pared to lamin B. The nuclear envelope and patches of
ELCS (bright yellow regions) appear to possess significant
local concentrations of both LBR and lamin B. Also shown
in Figure 6 (right column, arrow) is a cell containing
apoptotic bodies, exhibiting persistence of LBR staining,
with reduced lamin B reactivity, in agreement with obser-
vations that lamin B is degraded prior to LBR [21].
In an effort to better define the nature of the nuclei in dif-
ferentiating HL-60-bcl-2 cells, we explored their immu-
nostaining properties (Figure 7). Our results indicate that
main nuclei and many micronuclei contain centromeres
(reactivity with CREST antisera), heterochromatin (reac-
tivity with anti-dimethyl H3K9) and nucleolar staining.
Figure 7A also indicates that the Golgi apparatus (anti-
p58) retains its discrete juxtanuclear form in undifferenti-
ated and granulocytic cell types. In addition, the ER (anti-
calreticulin) is present in the spaces between nuclear lobes
Immunoblot of total cell extracts of RA treated HL-60-bcl-2  cells for up to three-weeks of differentiation Figure 4
Immunoblot of total cell extracts of RA treated HL-
60-bcl-2 cells for up to three-weeks of differentiation. 
Nuclear antigens: LBR, lamin B receptor; LMNB2, lamin B2; 
LMNB1, lamin B1; LMNA/C, lamin A/C; LAP2β; LAP2α; 
Emerin. The lanes contained comparable amounts of total 
proteins as judged by Ponceau S staining of the PVDF mem-
brane. Days following addition of RA are indicated.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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of granulocytic HL-60-bcl-2 cells. A confocal stereo image
of immunostained HL-60-bcl-2 cells is also presented in
Figure 7B, demonstrating a micronucleus deficient in LBR
and containing multiple centromeres. Micronuclei have
not been reported to occur in granulocytes or during gran-
ulopoiesis, underscoring that HL-60 cells are clearly
abnormal in certain aspects of nuclear and cellular physi-
ology (see [3] for other differences, compared to normal
granulocytes).
Retinoic acid induced nuclear differentiation of HL-60-bcl-
2 cells occurs in the presence of cytochalasin D
HL-60-bcl-2 were exposed to 1 µM CD with (or without)
1 µM RA for up to 7 days, cytospun onto microscope
slides, methanol-fixed, air-dried and stained with Wright-
Giemsa. The results were generally similar to those
described above for HL-60/S4 cells. Several examples of
Wright-Giemsa stained HL-60-bcl-2 cells treated with CD
or with RA plus CD are shown in Figure 1e,1f,1g,1h. Via-
bility of both the CD-only and the RA plus CD cells were
~60% by day 7. By day 2 following addition of CD with
(or without RA), ~70% of the cells were binucleated. A
slow progression to tri-, tetra- and >tetranucleated cells
was observed, leading to a population with ~20% mono-
, ~50% bi- and ~30% multinucleated cells by day 7. Lob-
ulation and ELCS formation was evident in the cells
exposed to RA for 7 days; but nuclei within the CD-only
cells also revealed distorted and folded nuclear shapes.
This was best observed when cytospun HCHO-fixed cells
were immunostained and viewed by confocal microscopy
Gallery of confocal immunofluorescent images of stained nuclei from undifferentiated HL-60-bcl-2 cells Figure 5
Gallery of confocal immunofluorescent images of stained nuclei from undifferentiated HL-60-bcl-2 cells. Cells 
were selected that demonstrate micronuclei adjacent to a main nucleus: LMNB, lamin B; LBR, lamin B receptor; DNA, TO-
PRO-3 stain. Notice that micronuclei frequently exhibit a relative deficiency of LBR compared to the main nuclei, but show 
comparable amounts of LMNB. Scale bar: 10 µm.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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(Figure 8). Therefore, it seems reasonable to conclude that
CD does not prevent nuclear lobulation and ELCS forma-
tion induced by RA. Furthermore, prolonged exposure to
CD alone exerts direct (or indirect) effects upon nuclear
shape in undifferentiated HL-60-bcl-2 cells.
Nocodazole prevents nuclear lobulation in retinoic acid 
treated HL-60-bcl-2 cells
HL-60-bcl-2 cells were exposed to 0, 0.1 or 1.0 µM NC,
with 1 µM RA for up to 10 days. Samples were harvested
for Wright-Giemsa staining at 1, 2, 3, 4, 7 and 10 days; for
immunostaining at day 8. Figure 9 summarizes the distri-
bution of nuclear profiles in the cytospun, methanol-
fixed, air-dried and Wright-Giemsa stained preparations.
The progressive disappearance of ovoid and increase in
indented and lobulated nuclear forms is clear when NC is
not present. On the other hand, the presence of 0.1 or 1.0
µM NC blocked the appearance of any significant num-
bers of indented or lobulated nuclear forms. Ovoid-
shaped nuclei were present in at least 80% of the NC-
treated cells. Immunostained preparations of 0.1 µM NC
treated cells (HCHO-fixed and not air-dried, to preserve 3-
D structure) are presented in Figures 10 and 11. The ovoid
nuclei give a slightly wrinkled appearance, with consider-
able surface infolding; but clearly not lobulations. Short
tufts of MTs could be visualized in juxtanuclear positions,
consistent with a general depolymerization of MTs. The
nuclear envelope exhibited clear staining with anti-lamin
B and anti-LBR. Nuclear interiors were stained with anti-
centromere, anti-nucleolar and anti-dimethylated H3K9
antisera. Anti-Golgi antibodies revealed some dispersion
of the p58 antigen. Dispersal of the Golgi resulting from
MT disruption is well documented [22]. In one set of
experiments (data not shown), NC was added to HL-60-
bcl-2 cells at day 2 or day 4 after the addition of RA and
nuclear morphology was observed on day 8. NC had a
clear inhibitory effect upon RA induced nuclear lobula-
tion, even when added 4 days after RA. Thus the inhibi-
tory effect of NC is not an early event in granulocytic
differentiation. As noted earlier, we have observed
essentially 100% cell death of HL-60/S4 cells exposed to
0.1 µM NC by day 2. Viability of HL-60-bcl-2 cells was
much better; but protection was not complete. By day 8 of
0.1 µM NC, viability had dropped to ~23%. This could
also be observed as increased levels of cellular debris in
the Wright-Giemsa stained slides. The cells shown in
Gallery of confocal images of LMNB and LBR stained nuclei during RA induced granulocytic differentiation Figure 6
Gallery of confocal images of LMNB and LBR stained nuclei during RA induced granulocytic differentiation. 
Note the increased lobulation and the persistence of micronuclei (frequently exhibiting a relative deficiency of LBR). The 
arrowhead points to an apoptotic cell with apoptotic bodies. Scale bar: 10 µm.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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Figures 10 and 11 were judged to have been viable prior
to fixation and staining, based upon the intactness of their
nuclear envelopes. Prolonged exposure of cells to NC has
clear detrimental effects. But within this limitation, it can
be concluded that exposure to NC prevents RA induced
nuclear lobulation in HL-60-bcl-2 cells.
Taxol treatment of HL-60-bcl-2 cells results in nuclear 
lobulation and micronuclei, independently of exposure to 
retinoic acid
As described earlier, addition of 0.1 µM TX to HL-60/S4
cells resulted in ~100% cell death by day 2, independently
of the presence (or absence) of RA. Apparently the cyto-
toxicity of TX is potentiated in cells with elevated levels of
c-myc [23]. HL-60 cells are well known to possess c-myc
amplification [24,25]. Preliminary studies with HL-60-
bcl-2 cells indicated that as early as day 2, addition of 0.1
or 1.0 µM TX resulted in the appearance of indented and
lobulated nuclei in the absence of RA. Consequently,
Wright-Giemsa staining analysis of TX treated cells (in the
absence of RA) was performed for up to 10 days (Figure
12; identical results were obtained in the presence of RA).
There was a rapid decline of cells with ovoid nuclei and a
corresponding increase of cells with indented and lobu-
lated nuclear forms. There was also a progressive increase
in cell death and debris in the stained preparations.
Indeed by day 4, HL-60-bcl-2 cells exposed to 0.1 µM TX
displayed only ~20% viability. Even so, there were a suffi-
cient number of viable cells to perform immunofluores-
cent staining. Besides the evident nuclear lobulation,
considerable numbers of cells revealed formation of
micronuclei. This, combined with the extensive bundling
of MTs, resulted in dramatic images of highly perturbed
cells (Figure 13). There was no obvious spatial
relationship between the positions of the MT bundles and
the nuclear lobulations and micronuclei. This may signify
that the action of TX on cells occurs earlier (e.g., disrup-
tion of the mitotic spindle), with later rearrangements
during interphase. TX induced micronuclei revealed hete-
rochromatin (anti-dimethylH3K9) and nucleolar materi-
als (Figure 14). Clearly, the dramatic effects of TX upon
Confocal immunofluorescent images of HL-60-bcl-2 cells Figure 7
Confocal immunofluorescent images of HL-60-bcl-2 cells. A. Gallery of undifferentiated and RA treated (7 days) cells. 
The columns (left to right) are: anti-centromere (CREST); anti-dimethyl H3K9; anti-nucleolus; anti-Golgi p58; anti-calreticulin. 
LMNB is always shown in green; the different antigens in red. Scale bar: 10 µm. B. Stereo image of undifferentiated HL-60-bcl-2 
cells stained with anti-centromere (red), anti-LMNB (blue) and anti-LBR (green). Note the presence of centromeres within a 
micronucleus, which exhibits a deficiency of LBR. Scale bar: 10 µm.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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nuclear shape do not depend upon the presence of RA. It
remains to be demonstrated whether these effects occur
by perturbation of interphase and/or mitotic MTs.
The centrosomal region retains its proximity to the nucleus 
in HL-60-bcl-2 cells under all conditions
The position of the centrosomal region was visualized
with monoclonal antibodies against γ-tubulin (Figure
15). In all the conditions tested (undifferentiated; RA
treated; RA and CD treated; TX treated), the centrosomal
region appeared to be near the nuclear envelope; often
surrounded by nuclear lobes in the RA treated cells. The
proximity of the centrosomal region to the nucleus in RA
treated HL-60-bcl-2 cells contrasts with earlier observa-
tions on RA treated "polarized" HL-60/S4 cells [4]. Light
microscope observations of living cells revealed fewer
polarized HL-60-bcl-2 cells, than previously observed for
HL-60/S4 cells (data not shown). It is possible that the
HL-60/S4 cells are more readily "activated", like normal
neutrophils, than are HL-60-bcl-2 cells. They also differen-
tiate to granulocytic form faster (~3 to 4 days), compared
to HL-60-bcl-2 cells (~7 days).
Discussion
HL-60-bcl-2 cells and granulocytic nuclear differentiation
Prolonged exposure of HL-60 cells to various cytoskele-
ton-modifying chemicals (i.e., nocodazole and taxol) are
very harmful to cell viability, inducing rapid apoptosis.
The present study was conducted primarily on a Bcl-2
overexpressing subline of HL-60 cells, which is more
refractory to apoptosis and exhibits the chemically
induced differentiation properties of the parent cell line
[18]. Lethal effects of NC or TX are delayed in HL-60-bcl-2
cells, compared to HL-60/S4 cells, allowing a window of
time for determining the effects of these MT modifying
chemicals on nuclear shape and nuclear differentiation.
There are two additional differences between HL-60-bcl-2
and HL-60 cells observed in this study. The first difference:
~10% of the undifferentiated HL-60-bcl-2 cells exhibit
Gallery of confocal images of CD treated undifferentiated and RA differentiated HL-60-bcl-2 cells Figure 8
Gallery of confocal images of CD treated undifferentiated and RA differentiated HL-60-bcl-2 cells. CD and RA 
treatment were for 7 days. The columns (left to right) are: anti-nucleolus; anti-Golgi p58; anti-α-tubulin. LBR is always shown in 
green; the other antigens in red.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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micronuclei, compared to ~0.8% of HL-60 cells [26].
Micronuclei are generally regarded as the products of
abnormal mitoses, where the enclosed chromosomes or
chromosome fragments fail to congress at the mitotic
plate, but are still surrounded by a post-mitotic nuclear
envelope [27-30]. In normal human cells growing in cul-
ture (e.g., lymphocytes), they occur in less than 0.5% of
the cells [31]. They can be induced in cells by treatment
with a variety of DNA breakage conditions (e.g., irradia-
tion) or spindle disrupting agents (e.g., colchicine).
Micronuclei in HL-60 cells are described as representing
amplified acentric euchromatic genes (such as c-myc) and
appear to form dynamically during S phase [32]. We
observed that micronuclei in HL-60-bcl-2 cells exhibited
immunostaining of centromeres, heterochromatin and
nucleolar antigens (Figure 7), which suggests differences
from the earlier interpretation of the nature of micronu-
clei in HL-60 cells.
Especially puzzling was our observation that the majority
of micronuclei possessed comparable amounts of lamin
B, but reduced amounts of LBR, in comparison to the
companion main nucleus. A recent study employing
MCF-7 cells observed micronuclei containing lamins A/C
and B1 and a relative deficiency of LBR [33]. The same
study demonstrated that when significant numbers of
micronuclei were induced by prolonged exposure to the
spindle disrupting chemical curcumin, the resulting
nuclear envelopes contained LBR. Current views on the
sequence of protein additions to post-mitotically
reformed nuclei agree that LBR enters the nascent nuclear
envelope well before lamin B [34,35]. It is possible that
untreated HL-60-bcl-2 and MCF-7 micronuclear enve-
lopes form later than the main nucleus, after the
cytoplasmic pool of LBR is exhausted, whereas curcumin
"induced" micronuclei form at about the same time as
main nuclei.
The second difference: RA treated HL-60-bcl-2 cells exhibit
a small population (up to 20%) with multilobed nuclei,
which we almost never observed with HL-60/S4 cells.
There may be some clinical significance to this latter
Nuclear differentiation in RA treated HL-60-bcl-2 cells exposed to varying concentrations of NC Figure 9
Nuclear differentiation in RA treated HL-60-bcl-2 cells exposed to varying concentrations of NC. Panels: 0, 0.1 
and 1.0 µM NC. The percentage of cells in each of the four nuclear categories from day 0 to day 10 (following addition of RA): 
ovoid; indented; lobulated; multilobed.
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observation. A small percent of granulocyte nuclei with 5
or more nuclear lobes in human blood smears is consid-
ered diagnostic for megaloblastic anemia (vitamin B12 or
folic acid deficiency) [20]. The present data with RA
treated HL-60-bcl-2 cells suggests that delayed or
dysfunctional apoptosis might play a role in these human
diseases. It is of interest that neutrophil nuclear multilob-
ulation (hypersegmentation) has been described in two
circumstances that delay apoptosis: 1) Glucocorticoid
administration to patients induces hypersegmentation
[36], and in vitro glucocorticoid treatment of neutrophils
prolongs their survival [37-39]. 2) Granulocyte colony-
stimulating factor (G-CSF) administration to rats induces
hypersegmentation in mature neutrophils [40], and in
vitro treatment of neutrophils with G-CSF prolongs their
survival [38,41].
Major cytoskeletal influences on nuclear shape in HL-60-
bcl-2
The most important present observation is the suppres-
sion of RA induced nuclear lobulation in HL-60-bcl-2 cells
by simultaneous exposure to NC (Figure 9). This observa-
tion implies that MTs must be intact during nuclear differ-
entiation. Furthermore, we have observed (data not
shown) that HL-60-bcl-2 cells can be made 0.1 µM NC on
day 2 or 4 after addition of RA, still exhibiting inhibition
of nuclear lobulation. This observation suggests that the
requirement for intact MTs is not an early event in the
nuclear differentiation process. When RA and NC treated
HL-60-bcl-2 cells were examined by confocal immunoflu-
orescent staining with anti-lamin B, the ovoid nuclei
revealed extensive "wrinkling" of the nuclear envelope
(Figures 10 and 11). We suggest that this "wrinkling"
Stereo confocal images of HL-60-bcl-2 cells exposed to 1.0 µM RA and 0.1 µM NC Figure 10
Stereo confocal images of HL-60-bcl-2 cells exposed to 1.0 µM RA and 0.1 µM NC. Treatment was for 8 days. The 
rows are: anti-centromere (CREST); anti-nucleolus; anti-α-tubulin. LMNB is always shown in green; the different antigens in 
red. Scale bar: 10 µm.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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reflects expansion (growth) of the nuclear envelope in the
absence of nuclear lobulation.
The present study demonstrates a lack of requirement of
an intact actin microfilament system for RA induced gran-
ulocytic nuclear differentiation (Figure 1). This conclu-
sion is based upon the observation that incubation of HL-
60/S4 and HL-60-bcl-2 cells with 1 µM CD in the presence
of RA does not inhibit nuclear lobulation or the forma-
tion of ELCS. Our results agree with an earlier study [17].
In addition, we extended the incubation (with CD and
RA) to times where nuclear differentiation is more defini-
tive. Our data also demonstrated that prolonged incuba-
tion with CD alone produces significant nuclear envelope
folding, which is best appreciated by confocal immunos-
taining of the nuclei (Figure 8). The mechanism for the
nuclear shape changes in undifferentiated cell nuclei
exposed to prolonged incubation with CD is presently
unknown. There is increasing evidence that actin microfil-
ament interactions with the nuclear envelope exist, medi-
ated via actin binding spectrin-like proteins, variously
named Syne 1 and 2/ nesprin-1 and 2/ ANC1/ NUANCE
[12-15]. However, a counter argument for the relevance of
this actin interacting system to nuclear differentiation in
the HL-60 cell system can be made. Nesprin-1 binds
directly to lamin A and emerin [14]; but undifferentiated
and granulocytic HL-60 cells possess negligible amounts
of lamin A, with emerin primarily localized in the cyto-
plasm [5]. Furthermore, published [13] and unpublished
data (A. Karakesisoglu, A. Olins and D. Olins) indicate
that HL-60 cells, undifferentiated or RA treated, possess
only trace amounts of NUANCE.
Confocal images of HL-60-bcl-2 cells exposed to 1.0 µM RA and 0.1 µM NC Figure 11
Confocal images of HL-60-bcl-2 cells exposed to 1.0 µM RA and 0.1 µM NC. Treatment was for 8 days. Left column: 
top, anti-LBR; middle, anti-dimethyl H3K9; bottom, anti-LMNB. Right column: top, anti-Golgi p58; middle, anti-LMNB; bottom, 
merge. LMNB is always shown in green. Scale bar: 10 µm.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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The finding that TX treatment of cells has dramatic conse-
quences to interphase nuclear structure has been reported
before. Exposure of human carcinoma cells (Ishikawa and
HeLa) to 0.01–0.1 µM TX for up 20 hours, followed by
incubation in drug-free media for up to 72 hours, led to
nuclear envelope "unraveling" and clustering of nuclear
pores [42]. The authors observed lobulated and micronu-
clei, much as observed here. In the case of HL-60-bcl-2, the
nuclear structural changes superficially mimic the effects
of RA treatment, but occur much faster (Figure 12). The
bundling of MTs in HL-60 cells in response to exposure to
1.0 µM TX for 24 hours has also been reported [43], but
no mention was made of the nuclear envelope changes.
Furthermore, the authors noted that at 0.1 µM TX (or
greater) the HL-60 cells showed clear apoptosis by 24
hours. In a later paper by the same group [44], increased
expression of Bcl-2 or Bcl-xL yielded HL-60 cells with con-
siderably greater resistance to TX induced apoptosis. It
seems to us that the dramatic cell and nuclear changes that
we observe have no obvious relationship to normal gran-
ulocytic nuclear lobulation, but underscore an effect of
MT integrity upon nuclear shape. The formation of
micronuclei, in particular, suggests that TX may exert its
effects on nuclear shape by interfering with normal
mitotic chromosome distribution.
A model for granulocytic nuclear lobulation
Although far from a complete understanding of all the
molecular forces involved in shaping the granulocytic
nucleus, a working model that incorporates existing data
and emerging concepts provides a useful perspective for
future experimentation (Figure 16). The process of
granulocytic nuclear lobulation can be viewed as a
dynamic balance of stabilizing and distorting forces. The
working model contains the following assumptions: 1)
the flexible nuclear envelope (due to the paucity of lamins
A/C and B1) is "tacked down" to the underlying hetero-
chromatin (enhanced by the elevated LBR); 2) the nuclear
envelope undergoes invaginations in the region of the
centrosome due to dynein movement along MTs; 3) new
Nuclear shape changes in undifferentiated HL-60-bcl-2 cells exposed to varying concentrations of TX Figure 12
Nuclear shape changes in undifferentiated HL-60-bcl-2 cells exposed to varying concentrations of TX. Panels: 0, 
0.1 and 1.0 µM TX. The percentage of cells in each of the four nuclear categories from day 0 to day 10: ovoid; indented; lobu-
lated; multilobed.
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membrane materials are added to the nuclear envelope
via lateral diffusion from the ER, resulting in net mem-
brane growth [3]; 4) constraints on nuclear shape by actin
and spectrin-like proteins are weak, due to the paucity of
lamins A/C and NUANCE and the cytoplasmic localiza-
tion of emerin; 5) constraints on nuclear shape by vimen-
tin-envelope interactions are minimal in the
differentiating HL-60 cell system.
We suggest that nuclear envelope deformability is an
important factor and depends upon the amount of under-
lying lamins: the less lamin protein, the more pliable the
nuclear envelope. Granulocytic forms of HL-60 exhibit
deficiency of lamins A/C and B1, whereas both types of
lamins are present in monocyte/macrophage forms [5].
The absence of lamins A/C in normal granulocytes and
their presence in macrophages has been previously noted
[45]. The present data on granulocytic differentiation in
HL-60-bcl-2 demonstrates that nuclear lobulation
correlates with low levels of lamins A/C and B1 coupled
with a rise in LBR levels (Figure 4).
The pivotal role of LBR in determining granulocytic
nuclear lobulation was demonstrated with the human
Pelger-Huet anomaly and murine Ichthyosis mutations
[8,9]. These studies demonstrated that LBR functions in a
Stereo confocal images of undifferentiated HL-60-bcl-2 cells exposed to 1.0 µM TX Figure 13
Stereo confocal images of undifferentiated HL-60-bcl-2 cells exposed to 1.0 µM TX. Treatment was for 4 days. 
Rows: top, control cells, unexposed to TX; middle and bottom, 4 days of TX. LMNB is shown in green; α-tubulin in red. Scale 
bar: 10 µm.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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dose-dependent manner: homozygous mutants present a
more severe phenotype and lower amounts of LBR, than
in the heterozygous state. The influence of LBR on
granulocytic nuclear lobulation is consistent with its
known properties [46]. LBR is embedded within the
nuclear envelope inner membrane via 8 transmembrane
domains (the C-terminal ~400 aa), and associated with
lamin B, chromatin and HP1α in the N-terminus (~200
aa). In the absence of sufficient LBR, nuclear lobulation is
prevented and the normally peripheral heterochromatin
is redistributed into a more centrally condensed form
[8,9].
A role for MT integrity is implicit in our present observa-
tion that exposure of HL-60-bcl-2 cells to NC prevents
nuclear lobulation during exposure of the cells to RA.
Direct interaction between MTs and the interphase
nuclear envelope in mammalian cells have not docu-
mented. However, a recent model for mitotic nuclear
envelope breakdown [47,48] can be adapted to the situa-
tion of nuclear lobulation. The nuclear envelope break-
down model proposes that cytoplasmic dynein attaches
MTs to the nuclear envelope, pulling the envelope
towards the centrosomal region. The excess envelope near
to the centrosome produces nuclear invaginations; the
tension on the non-growing nuclear envelope generates
tears and the mixing of nuclear and cytoplasmic materials.
If we assume that the nuclear envelope is still growing in
the case of RA differentiating HL-60 cells, invaginations
and lobulations might be expected to accumulate within
the intact nuclear envelope. The present study
demonstrates proximity of the centrosome to nuclear lob-
Stereo confocal images of undifferentiated HL-60-bcl-2 cells exposed to 1.0 µM TX Figure 14
Stereo confocal images of undifferentiated HL-60-bcl-2 cells exposed to 1.0 µM TX. Treatment was for 4 days. 
Rows: top, anti-nucleolus; middle, anti-dimethyl H3K9; bottom, anti-Golgi p58. LMNB is shown in green; other antigens in red. 
Scale bar: 10 µm.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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ulation (Figure 15). But as yet, there is no direct evidence
for cytoplasmic dynein playing a role in granulocytic
nuclear differentiation.
Our present data suggests that an intact actin microfila-
ment system does not play a major role in granulocytic
nuclear lobulation (Figure 1). The best described
mechanism of actin interacting with the nuclear envelope
involves spectrin-like proteins, which may bridge cyto-
plasmic actin to nuclear envelope proteins, such as lamin
A and emerin [12-15]. But undifferentiated and
granulocytic HL-60 cells possess very little lamin A/C and
emerin is primarily cytoplasmic [5], suggesting that this
bridging system may not be functional in these cell forms.
In SW-13 cells the absence of intermediate filaments
(vimentin) has been correlated with nuclear envelope
folds or invaginations [16]. We have observed a decrease
in vimentin during differentiation of granulocytic HL-60/
S4 cells [3-5], suggesting that reduced vimentin concentra-
tions may contribute to granulocytic nuclear lobulation.
The proposed model for granulocytic nuclear lobulation
yields several testable predictions: 1) Expression of lamins
A/C and B1 in HL-60 cells should strengthen the nuclear
envelope, minimizing nuclear lobulation following expo-
sure of the cells to RA; 2) "Knock-down" or expression of
a "dominant negative" form of LBR in HL-60 cells would
be expected to suppress granulocytic lobulation; 3) Over-
expression of dynamitin in HL-60 cells should inhibit
dynein activity [49], preventing nuclear lobulation fol-
lowing RA induced differentiation. A number of these
experiments are already in progress.
Conclusions
Employing Bcl-2 overexpressing HL-60 cells, which are
more refractory to induced apoptosis than the parent cell
line, we demonstrated that disruption of the MTs by noc-
odazole prevented nuclear lobulation in response to RA
treatment. These results implicate the necessity of an
intact MT system for granulocytic nuclear shape.
Cytochalasin D, on the other hand, did not suppress RA
induced nuclear lobulation. Combined with the decreas-
ing levels of intermediate filaments (vimentin) during dif-
ferentiating granulocytic forms of HL-60 cells, the role of
the MT system appears to be quite central to the nuclear
shape change. Recent models on the role of a MT bound
motor (dynein) in facilitating mitotic nuclear envelope
breakdown suggest that similar tension forces on the dif-
ferentiating granulocyte nucleus, combined with
continued influx of nuclear envelope components, could
explain nuclear invaginations and lobulation.
Methods
Cells and chemicals
Two HL-60 cell sublines were employed in this study: HL-
60/S4 [50], which achieves maximum nuclear lobulation
in 4 days following addition of RA; HL-60-bcl-2 [18],
which achieves maximum lobulation in ~7 days, compa-
rable to the parent cell line. Cultivation conditions were
exactly as described previously [3,4].
The following chemicals were purchased from Sigma-
Aldrich (St. Louis, MO): all-trans retinoic acid (RA), noco-
dazole (NC), taxol (TX), cytochalasin D (CD). Stock solu-
tions of these chemicals were stored at -20°C as described
earlier [3,4].
Confocal images of HL-60-bcl-2 cells immunostained for γ-tubulin Figure 15
Confocal images of HL-60-bcl-2 cells immunostained for γ-tubulin. Cell treatments: 0, undifferentiated; RA, 7 days; 
RA + NC, 7 days with 1 µM RA and 0.1 µM NC; TX, 3 days with 1 µM TX. γ-tubulin is shown in red; LBR in green. Scale bar: 
10 µm.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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Model for granulocytic nuclear lobulation Figure 16
Model for granulocytic nuclear lobulation. A. Postulated changes in nuclear envelope flexibility arising from changes in 
nuclear envelope composition. HL-60 cell states: undifferentiated; granulocyte, RA treated; monocyte, TPA treated. Abbrevia-
tions: inm, inner nuclear membrane; LMNB2, lamin B2; LMNA/C, lamins A/C; LMNB1, lamin B1; HP1, heterochromatin protein 
1; LBR, lamin B receptor. Due to a paucity of lamins A/C and B1, the nuclear envelope is believed to be more flexible in the 
undifferentiated and granulocytic cell states. B. Balance of forces postulated to be affecting granulocytic nuclear shape. Microtu-
bules (green) and affiliated dynein motors (red circles) are assumed to produce nuclear envelope invaginations (bent arrows). 
Actin with affiliated spectrin-like proteins and vimentin are assumed to be pulling outwards on the nuclear envelope (thin 
arrows). Current evidence does not favor a major contribution by actin; any significant contribution by vimentin is presently 
unknown. The large straight arrows indicate continued influx of nuclear envelope components from the endoplasmic reticu-
lum, allowing sustained membrane growth. Abbreviations: MTs, microtubules; IFs, intermediate filaments; ER, endoplasmic 
reticulum; Eu, euchromatin; H, heterochromatin. The nuclear compartment is colored blue; the cytoplasm, pink.BMC Cell Biology 2004, 5:30 http://www.biomedcentral.com/1471-2121/5/30
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Antibodies
Guinea pig antisera were the generous gifts of two Ph. D.
students in the laboratory of H. Herrmann (German Can-
cer Research Center, Heidelberg): anti-LBR and anti-
emerin, from C. Dreger; anti-lamin A and anti-lamin B1,
from J. Schumacher. Goat anti-lamin B was obtained from
Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Rabbit
anti-4 × dimethyl H3K9 (lysine 9 on histone 3) was gen-
erously provided by T. Jenuwein (Biocenter, Vienna).
Human auto-antisera anti-centromere (CREST) and anti-
nucleolus (antigens unknown) were purchased from Anti-
bodies Inc. (Davis, CA). Rabbit anti-calreticulin was from
Calbiochem (San Diego, CA). Mouse monoclonal anti-
bodies against α-tubulin, γ-tubulin and Golgi p58 were all
purchased from Sigma-Aldrich. Mouse monoclonal anti-
vimentin (3B4) was a gift of H. Herrmann and has been
described before [51]. FITC-, Cy3-, Cy5- and HRP-conju-
gated donkey secondary antibodies were all purchased
from Jackson ImmunoResearch Laboratory, Inc. (West
Grove, PA). TO-PRO-3 and SlowFade were obtained from
Molecular Probes, Inc. (Eugene, OR).
Fixation and staining
For Wright-Giemsa staining, cells were cytospun onto eth-
anol-cleaned microscope slides, fixed in room tempera-
ture methanol for 15 min, air-dried and stained as
described earlier [3]. For analysis of the percentage of cells
in the various nuclear morphology categories (Figures 3, 9
and 12), approximately 150 cells were observed and clas-
sified in each experiment.
In the majority of immunostaining experiments the pro-
cedure followed that described previously [4], with some
modifications, as follows: 1) Microscope slides were
soaked overnight in 1/1 ethanol/ether and freshly coated
with poly-L-lysine (MW ~150–300,000; Sigma-Aldrich),
just before centrifugation of the cells. 2) No coverslip was
used during antibody incubations, to minimize loss of
cells. 3) Prior to the application of primary antibodies,
slides were incubated with 5% normal donkey serum
(Jackson ImmunoResearch Laboratory) in PBS for 15–30
min at 37°C in a moist chamber. 4) In the cases of mon-
oclonal anti-γ-tubulin and anti-vimentin, where anti-
genicity appeared to be destroyed by HCHO fixation,
slides were fixed in methanol (-20°C, 10 min), acetone (-
20°C, 1 min) followed by three washes in PBS (5 min
each). The cells were not excessively flattened by either
procedure, maintaining sufficient 3-D structure to justify
stereo viewing. Confocal images were collected on a Zeiss
510 Meta. Stereo images were obtained as ± 15° projec-
tions through the stack of confocal images.
Immunoblot analysis
SDS total cell extracts, obtained from undifferentiated and
RA treated HL-60-bcl-2 cells over a three-week period
(simultaneously with preparation of slides for Wright-
Giemsa staining), were analyzed by immunoblotting as
previously described [5]. No attempt was made to sepa-
rate viable cells from debris prior to SDS extraction. Com-
parable amounts of total cell protein were loaded into
each lane of the SDS-PAGE, as judged by Ponceau S stain-
ing of the PVDF membrane after protein transfer. Several
different ECL exposures were collected on X-ray film and
subsequently scanned with a Bio Rad Chemi Doc for den-
sitometric analyses.
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